 |
|
| GENOMICS IN CANCER DRUG DISCOVERY AND DEVELOPMENT, 96
| |
| | |
|
|
To order this title, and for more information, click here
George Vande Woude, Director, Van Andel Research Institute, Grand Rapids, MI, USA
Garret Hampton, Celgene Signal Research, San Diego, CA, U.S.A.
George Klein, Karolinska Insitutet, Stockholm, Sweden
Karol Sikora, Professor, Hammersmith Hospital, Hammersmith, U.K.
Included in series
Advances in Cancer Research,
Description
The Advances in Cancer Research series provides invaluable information on the exciting and fast-moving field of cancer
research. This volume stands as the first ever thematic volume in the series, focusing on the topic of genomics in cancer drug development.
The chapters included in this book represent the cutting-edge information in the field and span such topics as Mass Spectrometry: Uncovering
the Cancer Proteome for Diagnostics; Biomarker Discovery in Epithelial Ovarian Cancer by Genomic Approaches; The Application of siRNA
Technology to Cancer Biology Discovery; Ribozyme Technology for Cancer Gene Target Identification and Validation; Cancer Cell-Based Genomic
and Small Molecule Screens; Tumour Antigens as Surrogate Markers and Targets for Therapy and Vaccines; Practices and Pitfalls of Mouse
Cancer Models in Drug Discovery; Biomarker Assay Translation from Discovery to Clinical Studies in Cancer Drug Development – Quantification
of Emerging Protein Biomarkers; Molecular Optical Imaging of Therapeutic Targets of Cancer; Cancer Drug Approval in the United States,
Europe and Japan.
Audience
Researchers and students in the basic and clinical science of cancer biology and oncology, plus related areas in genetics, immunology, pharmacology, cell biology and molecular biology.
Contents
Mass Spectrometry: Uncovering the Cancer Proteome for Diagnostics.
Biomarker Discovery in Epithelial Ovarian Cancer by Genomic Approaches.
The Application of siRNA Technology to Cancer Biology Discovery.
Ribozyme Technology for Cancer Gene Target Identification and Validation.
Cancer Cell-Based Genomic and Small Molecule Screens.
Tumour Antigens as Surrogate Markers and Targets for Therapy and Vaccines.
Practices
and Pitfalls of Mouse Cancer Models in Drug Discovery.
Biomarker Assay Translation from Discovery to Clinical Studies in Cancer Drug
Development – Quantification of Emerging Protein Biomarkers.
Molecular Optical Imaging of Therapeutic Targets of Cancer.
Cancer Drug
Approval in the United States, Europe and Japan.
| Bibliographic details |
Hardbound, 432 pages, publication date: DEC-2006
ISBN-13: 978-0-12-006696-4
ISBN-10: 0-12-006696-3
Imprint: ACADEMIC PRESS
|
| Price and Ordering |
Price:
USD 150
EUR 106.95
GBP 90.99
|  |
Books and book related electronic products are priced in US dollars (USD), euro (EUR), and Great Britain Pounds (GBP). USD prices apply to the Americas and Asia Pacific. EUR prices apply in Europe and the Middle East. GBP prices apply to the UK and all other countries.
|
See also information about conditions of sale & ordering procedures, and links to our regional sales offices.
|
090/925
Last update: 3 Oct 2009
|
|
| |
| | |
|
|
| |
Home | Elsevier Sites | Privacy Policy | Terms and Conditions | Feedback | Site Map | A Reed Elsevier Company